TRIMPACT: Real-World First-Line Atezolizumab Use in Stage IV NSCLC With PD-L1 ≥50%

Clinical trial NCT07279402 · RECRUITING

Trial details

NCT number: NCT07279402
Sponsor: Antalya Training and Research Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

NSCLC Stage IV PD-L1 Gene Mutation Atezolizumab Real World Study

Start date: 2025-09-15
Primary completion: 2027-05-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.